Content Validation by Patients and Experts: Is the PRO Measure Fit for Purpose?

The use of a PRO measure assumes a link between the content in a measure and the targeted underlying construct (Wynd et al. 2003). In addition to other types of data, this is fundamentally demonstrated by evidence of content validity, i.e. the ‘complete relevance’ of the content to the target population and how adequately it represents the underlying construct. Without such evidence, the definition of the underlying concept being measured becomes ambiguous, and the scores would be rendered meaningless (Haynes et al. 1995). While evidence ensuring content validity is generated through inclusion of input from patients in defining the content of the measure, confirming that ‘complete relevance’ has been attained is crucial. This is addressed in Steps IV and V of the roadmap, where respondent understanding of the measure and comprehensives is explicitly explored in Step IV, with practicality and acceptability explored in Step V. Importantly, both steps allow the PRO measure to be fine-tuned to address any issues uncovered in the steps. These steps are illustrated in the current chapter, based on the patient and clinician panels conducted to assess the content validity of the HidroQoL as well as a pilot test of the measure assessing the practicality and acceptability of the HidroQoL.

[1]  H. Wulf,et al.  Patient–physician consensus on quality of life in dermatology , 1996, Clinical and experimental dermatology.

[2]  C. Terwee,et al.  Quality criteria were proposed for measurement properties of health status questionnaires. , 2007, Journal of clinical epidemiology.

[3]  I J Higginson,et al.  Using quality of life measures in the clinical setting , 2001, BMJ : British Medical Journal.

[4]  S. Haynes,et al.  Content validity in psychological assessment: A functional approach to concepts and methods. , 1995 .

[5]  Elizabeth Molsen,et al.  Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2--assessing respondent understanding. , 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[6]  D A Revicki,et al.  Recommendations for evaluating the validity of quality of life claims for labeling and promotion. , 1999, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[7]  C. Wynd,et al.  Two Quantitative Approaches for Estimating Content Validity , 2003, Western journal of nursing research.

[8]  R. Hays,et al.  Content validity of patient-reported outcome measures: perspectives from a PROMIS meeting , 2012, Quality of Life Research.

[9]  Gordon Guyatt,et al.  Measuring Health-Related Quality of Life , 1993, Annals of Internal Medicine.

[10]  D. Streiner,et al.  Health measurement scales , 2008 .

[11]  K. Lohr,et al.  Applying cognitive design principles to formatting HRQOL instruments , 2000, Quality of Life Research.

[12]  M. Lynn Determination and quantification of content validity. , 1986, Nursing research.

[13]  D. Streiner,et al.  Health Measurement Scales: A practical guide to thier development and use , 1989 .

[14]  N. Santanello,et al.  Choice of recall period for patient-reported outcome (PRO) measures: criteria for consideration , 2012, Quality of Life Research.